当代浸润性上尿路尿路上皮癌的发病率和生存率
非转移性患者行根治性肾输尿管切除术,分期、分级、年龄和性别是癌症特异性死亡的独立预测因素;转移性患者中化疗、根治性手术和输尿管原发与更低总死亡风险相关。
要点
- UTUC总体发病率下降,但转移性UTUC发病率上升。
- 非转移性UTUC中T3N0M0、T4N0M0和T1-4N1-2M0分别占28.9%、4.6%和10.0%。
- 转移性UTUC中化疗和根治性肾输尿管切除术对总死亡有保护作用,输尿管原发预后更好。
核心结论
- UTUC总体年龄标化发病率下降,但转移性UTUC发病率上升。
主要发现
- UTUC总体年龄标化发病率从1.3降至1.1例/10万人年(平均年度百分比变化-1.32%,p=0.002)。
- T1-2N0M0期年龄标化发病率下降(平均年度百分比变化-2.77%,p<0.001),而T1-4N0-2M1期上升(平均年度百分比变化+2.87%,p<0.01)。
- 非转移性UTUC行根治性肾输尿管切除术后,分期、分级、年龄和性别是癌症特异性死亡的独立预测因素(p<0.001)。
- 转移性UTUC中,化疗、根治性肾输尿管切除术和输尿管原发是总死亡更低的独立预测因素。
关键数值与推荐
- 非转移性UTUC中T3N0M0、T4N0M0和T1-4N1-2M0分别占所有发病病例的28.9%、4.6%和10.0%。
临床怎么用
- 转移性UTUC患者可考虑化疗和根治性肾输尿管切除术以改善总生存。
- 输尿管原发转移性UTUC患者生存预后更好。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Contemporary incidence and mortality rates of upper tract urothelial carcinoma (UTUC) are unavailable. OBJECTIVE: To describe contemporary UTUC incidence and mortality rates in the USA. DESIGN, SETTING, AND PARTICIPANTS: Within the Surveillance, Epidemiology and End Results (SEER) database (2004-2016), we identified 13 075 UTUC patients. Of all, 9208 (70.4%) harbored nonmetastatic UTUC and were treated with radical nephroureterectomy versus 1174 (9.0%) who harbored metastatic UTUC. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Age-standardized incidence rates per 100 000 person years were calculated. Kaplan-Meier curves and multivariable Cox regression models addressed cancer-specific and overall mortality. RESULTS AND LIMITATIONS: Overall UTUC age-standardized incidence rates decreased from 1.3 to 1.1 cases per 100 000 person years (average annual percentage change: -1.32%, p = 0.002). Moreover, age-standardized incidence rates decreased for T1-2N0M0 (average annual percentage change: -2.77%, p < 0.001) but increased for T1-4N0-2M1 stage (average annual percentage change: +2.87%, p < 0.01). In nonmetastatic UTUC treated with radical nephroureterectomy, stage, grade, age, and sex (p < 0.001) were independent predictors in multivariable Cox regression models focusing on cancer-specific mortality. In metastatic UTUC, chemotherapy administration, radical nephroureterectomy treatment, and ureteral primary were independent predictors of lower overall mortality in multivariable Cox regression models. CONCLUSIONS: Although overall incidence of UTUC decreased, the incidence of metastatic UTUC increased over the study period. The majority of nonmetastatic UTUC harbored T1N0M0 stage. However, T3N0M0, T4N0M0, and T1-4N1-2M0 stages, respectively, affected 28.9%, 4.6%, and 10.0% of all incident cases. In metastatic UTUC, both chemotherapy and radical nephroureterectomy use exerted an important protective effect on overall mortality, and ureteral primaries exhibited more favorable survival. PATIENT SUMMARY: From 2004 to 2016, the incidence of upper tract urothelial carcinoma decreased in the USA. However, more advanced stages are on the rise.
引用
- Collà Ruvolo C, Nocera L, Stolzenbach LF, et al. Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma. Eur Urol Oncol. 2020. PMID: 33293235. doi:10.1016/j.euo.2020.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。